Our strong third quarter performance was enabled by the extraordinary work of our teams, who remained agile and resilient in today’s challenging operating environment. We are realizing the benefits of the successful strategy we implemented almost two years ago- which is particularly attuned to times of crisis- and of Genomma’s ability to adapt our advantaged product portfolio to address consumers’ ever evolving needs. During the quarter our Company’s exceptional innovation, go-to-market capabilities and strengthened presence within critical channels again drove outstanding year-on-year and sequential results.” He added: “Our team’s resilient mindset, combined with Genomma’s strategic capabilities and execution excellence, continue to turn challenges into opportunities. I’d like to express my deepest gratitude, pride and appreciation for the extraordinary performance across our organization which enable us to empower people to have excellent health and well-being.
Chief Executive Officer
October 21, 2020